title: Controversial issues regarding the use of induction chemotherapy for lung cancer.
abstract: Induction chemotherapy has been proven to improve survival in patients with Stage IIIA non-small cell lung cancer, and is under investigation for early stage disease. Controversy still exists regarding the choice of chemotherapy regimens, patient selection, and inclusion of radiation therapy.
authors.affiliation: Division of Thoracic Surgery, Duke University Medical Center, Durham, NC 27710, USA. damic001@mc.duke.edu
authors.forename: B Zane
authors.initials: BZ
authors.lastname: Atkins
authors.forename: Thomas A
authors.initials: TA
authors.lastname: D'Amico
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000601:surgery*; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery*; D020360:Neoadjuvant Therapy